References
- Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions. Ophthalmology. 2004;111(5):997–1008. doi:10.1016/j.ophtha.2003.01.002.
- Margo CE, Mulla ZD. Malignant tumors of the orbit. analysis of the Florida cancer registry. Ophthalmology. 1998;105(1):185–190. doi:10.1016/S0161-6420(98)92107-8.
- Fitzpatrick PJ, Macko S. Lymphoreticular tumors of the orbit. Int J Radiat Oncol Biol Phys. 1984;10(3):333–340. doi:10.1016/0360-3016(84)90051-8.
- Martinet S, Ozsahin M, Belkacémi Y, et al. Outcome and prognostic factors in orbital lymphoma: A rare cancer network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55(4):892–898.doi:10.1016/S0360-3016(02)04159-7.
- Kiesewetter B, Lukas J, Kuchar A, et al. Clinical Features, Treatment and outcome of Mucosa-Associated Lymphoid Tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients. Ganti AK, ed. PLoS One. 2014;9(7):e104004. doi:10.1371/journal.pone.0104004.
- Karlin J, Peck T, Prenshaw K, Portell CA, Kirzhner M. Orbital mantle cell lymphoma presenting as myasthenia gravis. Orbit. 2017;36(6):365–369. doi:10.1080/01676830.2017.1337202.
- Sriram P. A rare case of aggressive, huge primary orbital lymphoma with intracranial extension and bone invasion. Asian J Neurosurg. 2016;12(4):766. doi:10.4103/1793-5482.185055.
- Eckardt AM, Lemound J, Rana M, Gellrich N-C. Orbital lymphoma: diagnostic approach and treatment outcome. World J Surg Oncol. 2013;11:73. doi:10.1186/1477-7819-11-73.
- Freedman K, Shenoy S. Mucosa-associated lymphoid tissue lymphoma with intraocular and orbital involvement: case presentation and review of the literature. Orbit. October 2017:1–5. doi:10.1080/01676830.2017.1383479.
- Olsen TG, Heegaard S. Orbital lymphoma. Surv Ophthalmol. 2019;64(1):45–66. doi:10.1016/J.SURVOPHTHAL.2018.08.002.
- Olsen TG, Holm F, Mikkelsen LH. et al. Orbital Lymphoma—an international multicenter retrospective study. Am J Ophthalmol. 2019;199:44–57. doi:10.1016/J.AJO.2018.11.002.
- Jenkins C, Rose GE, Bunce C, et al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol. 2000;84(8):907–913.doi:10.1136/bjo.84.8.907.
- National Cancer Institute. SEER incidence database. https://seer.cancer.gov/data/. Accessed May 23, 2018.
- The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 2002;329(14):987–994. doi:10.1056/nejm199309303291402.
- Gatter K, Pezzella F. Diffuse large B-cell lymphoma. Diagnostic Histopathol. 2010;16(2):69–81. doi:10.1016/J.MPDHP.2009.12.002.
- Aozasa K, Ueda T, Kurata A, et al. Prognostic value of histologic and clinical factors in 56 patients with gastrointestinal lymphomas. Cancer. 1988;61(2):309–315.doi:10.1002/1097-0142(19880115)61:2<309::AID-CNCR2820610221>3.0.CO;2-J.
- Aozasa K, Inoue A, Tajima K, Miyauchi A, Matsuzuka F, Kuma K. Malignant lymphomas of the thyroid gland: analysis of 79 patients with emphasis on histologic prognostic factors. Cancer. 1986;58(1):100–104. doi:10.1002/1097-0142(19860701)58:1<100::AID-CNCR2820580118>3.0.CO;2-1.
- Ahmed AH, Foster CS, Shields CL. Association of disease location and treatment with survival in diffuse large B-cell lymphoma of the eye and ocular adnexal region. JAMA Ophthalmol. 2017;135(10):1062–1068. doi:10.1001/jamaophthalmol.2017.3286.
- Moslehi R, Coles FB, Schymura MJ. Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin’s lymphoma. Expert Rev Ophthalmol. 2011;6(2):175–180. doi:10.1586/eop.11.16.
- Hassan WM, Alfaar AS, Bakry MS, Ezzat S. Orbital tumors in USA: difference in survival patterns. Cancer Epidemiol. 2014;38(5):515–522. doi:10.1016/j.canep.2014.07.001.
- Hassan WM, Bakry MS, Hassan HM, Alfaar AS. Incidence of orbital, conjunctival and lacrimal gland malignant tumors in USA from surveillance, epidemiology and end results, 1973-2009. Int J Ophthalmol. 2016;9(12):1808–1813. doi:10.18240/ijo.2016.12.18.
- Rasmussen P, Sjo LD, Prause JU, Ralfkiaer E, Heegaard S. Mantle cell lymphoma in the orbital and adnexal region. Br J Ophthalmol. 2009;93(8):1047–1051. doi:10.1136/bjo.2008.146910.
- Cohen SM, Petryk M, Varma M, Kozuch PS, Ames ED, Grossbard ML. Non-Hodgkin’s lymphoma of mucosa-associated lymphoid tissue. Oncologist. 2006;11(10):1100–1117. doi:10.1634/theoncologist.11-10-1100.
- Swerdlow SH, World Health Organization, International Agency for Research on Cancer. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. http://publications.iarc.fr/Book-And-Report-Series/Who-Iarc-Classification-Of-Tumours/Who-Classification-Of-Tumours-Of-Haematopoietic-And-Lymphoid-Tissues-2017. Accessed March 2, 2019.
- Sedgwick P. Retrospective cohort studies: advantages and disadvantages. BMJ. 2014;348(jan24 1):g1072–g1072. doi:10.1136/bmj.g1072.